Pacira BioSciences, Inc. (PCRX)

Pacira BioSciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	1,058	1,567	1,772	2,680	2,600	1,890
Market Cap Growth	-27.55%	-11.56%	-33.90%	3.10%	37.52%	6.88%
Enterprise Value	1,314	1,874	2,246	3,153	2,619	1,950
PE Ratio	15.68	37.35	111.35	63.85	17.86	-171.60
PS Ratio	1.55	2.32	2.66	4.95	6.05	4.49
PB Ratio	1.19	1.80	2.29	3.67	4.20	5.33
P/FCF Ratio	6.11	11.23	15.38	33.57	66.27	31.32
P/OCF Ratio	5.73	10.13	12.19	21.32	33.75	26.81
EV/Sales Ratio	1.93	2.78	3.37	5.82	6.10	4.63
EV/EBITDA Ratio	6.91	11.89	15.52	27.01	39.88	60.09
EV/EBIT Ratio	11.35	22.86	42.16	35.76	57.24	151.43
EV/FCF Ratio	7.59	13.44	19.50	39.48	66.76	32.31
Debt / Equity Ratio	0.65	0.67	0.99	1.55	0.87	0.99
Debt / EBITDA Ratio	3.06	3.72	5.27	9.67	8.24	10.84
Debt / FCF Ratio	3.36	4.20	6.63	14.14	13.79	5.83
Quick Ratio	4.58	3.94	2.62	1.44	2.27	3.15
Current Ratio	5.81	5.24	3.37	1.66	2.57	3.79
Asset Turnover	0.44	0.44	0.38	0.36	0.41	0.54
Interest Coverage	8.26	4.04	1.33	2.78	1.78	0.55
Return on Equity (ROE)	8.30%	5.10%	2.10%	6.00%	29.60%	-3.20%
Return on Assets (ROA)	4.50%	2.70%	0.90%	2.80%	13.90%	-1.40%
Return on Capital (ROIC)	4.88%	4.09%	4.67%	3.60%	28.92%	1.48%
Earnings Yield	6.66%	2.68%	0.90%	1.57%	5.60%	-0.58%
FCF Yield	16.36%	8.90%	6.50%	2.98%	1.51%	3.19%
Buyback Yield / Dilution	-13.59%	-11.69%	-1.99%	-4.46%	-5.22%	-1.47%
Total Shareholder Return	-13.59%	-11.69%	-1.99%	-4.46%	-5.22%	-1.47%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).